Curtis Dale's most recent trade in Alaunos Therapeutics Inc was a trade of 3,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 29, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Alaunos Therapeutics Inc | Dale Curtis Hogue | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2025 | 3,000 | 3,000 | - | - | Employee Stock Option (right to buy) | |
Alaunos Therapeutics Inc | Curtis Dale Hogue | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2024 | 600,000 | 600,000 | - | - | Employee Stock Option (right to buy) | |
Alaunos Therapeutics Inc | Dale Curtis Hogue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
Alaunos Therapeutics Inc | Curtis Dale Hogue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 41,667 | 41,667 | - | - | Employee Stock Option (right to buy) |